Design and implementation of a cohort study of persons living with HIV infection who are initiating medication treatment for opioid use disorder to evaluate HIV-1 persistence
Background: Opioid use disorder (OUD) negatively impacts the HIV continuum of care for persons living with HIV (PLH). Medication treatment for OUD (MOUD) may have differential biological effects in individuals with HIV and OUD. To understand the role of MOUD – opioid agonist methadone, partial agoni...
Guardado en:
Autores principales: | Alysse Schultheis, Mark Sanchez, Savannah Pedersen, Tassos Kyriakides, Ya-Chi Ho, Yuval Kluger, Sandra A. Springer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2814f92706174e649e0ad90fdfc5205c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
por: Kim A. Hoffman, et al.
Publicado: (2021) -
Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Michael Soyka
Publicado: (2021) -
A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder
por: Alina Cernasev, et al.
Publicado: (2021) -
Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
por: Daoust R, et al.
Publicado: (2020) -
Rural community pharmacist willingness to dispense Suboxone® - A secret shopper investigation in South-Central Appalachia
por: Grace Trull, et al.
Publicado: (2021)